DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE2475.60-11.9 (-0.48 %)
PREV CLOSE(Rs.)2487.50
OPEN PRICE(Rs.)2450.00
BID PRICE (QTY) 2474.20 (10)
OFFER PRICE (QTY) 2475.60 (20)
VOLUME 36147
TODAY'S LOW / HIGH(Rs.)2430.00 2516.85
52 WK LOW / HIGH(Rs.)1901.65 3175
NSE2473.85-16.5 (-0.66 %)
PREV CLOSE(Rs.)2490.35
OPEN PRICE(Rs.)2440.00
BID PRICE (QTY) 2473.85 (39)
OFFER PRICE (QTY) 2473.95 (200)
VOLUME 418033
TODAY'S LOW / HIGH(Rs.)2440.00 2519.00
52 WK LOW / HIGH(Rs.)1901.15 3177

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs)
894.86
Dividend Yield(%)
0.81
TTM EPS (Rs.)
45.52
P/E Ratio
54.34
Book Value (Rs.)
681.98
Face Value (Rs.)
5
MCap (Rs. in Mn)
410412.28
Price/Earning (TTM)
27.10
Price/Sales (TTM)
4.49
Price/Book (MRQ)
3.63
PAT Margin (%)
14.24
ROCE (%)
11.00
Incorporation Year : 24-02 1984

Management Info :

K Satish Reddy - Chairman GV Prasad - Managing Director

Registered Office :

Address : 8-2-337, Road No. 3,Banjara Hills,,
Hyderabad,
Telangana-500034

Phone : 040 - 4900 2900

Website : www.drreddys.com

Registrars Details :

Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
18Jan TCS, Dr Reddy’s and Ashoka Buildcon to
Tata Consultancy Services (TCS) has expended its strategic partnership w..
18Jan Dr. Reddy’s recalls single lot of Doce
Dr. Reddy’s Laboratories has recalled a single lot of Docetaxel injectio..
16Jan Press Release / Media Release (Revised)
Dr. Reddy's to release Q3 FY18 results on January 25, 2018 Earnings cal..
Financials
QTR Sep 17 ANNUAL 17
Net Profit100713841
Gross Profit 1402 15445
Operating Profit 3540 23368
Net Sales 22543 97198
Rs. in Millions
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Valiant Organics (BSE)
 848.95 (8.84%)
M.Cap (Rs. in Cr)309.04
Abbott India (BSE)
 5520.00 (0.98%)
M.Cap (Rs. in Cr)11729.61
Alkem Laboratories (BSE)
 2247.85 (1.77%)
M.Cap (Rs. in Cr)26876.42
Lincoln Pharma (BSE)
 270.00 (13.85%)
M.Cap (Rs. in Cr)510.00
Shareholding Pattern
PROMOTERS
26.76%
NON-INSTITUTION
15.19%
MUTUAL FUNDS/UTI
9.33%
FI/BANKS/INSURANCE
5.96%
GOVERNMENT
0%
FII
0%
close X

Download Client Registration Documents